CNTA logo

CNTA
Centessa Pharmaceuticals PLC - ADR

293
Mkt Cap
$3.65B
Volume
3.00
52W High
$30.58
52W Low
$9.60
PE Ratio
-14.93
CNTA Fundamentals
Price
$27.18
Prev Close
$29.57
Open
$26.69
50D MA
$25.38
Beta
1.16
Avg. Volume
2.57M
EPS (Annual)
-$2.06
P/B
12.12
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Armistice Capital LLC Lowers Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA
Armistice Capital LLC decreased its position in shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Free Report) by 14.5% during the second quarter, according to its most recent...
MarketBeat·3h ago
News Placeholder
More News
News Placeholder
Centessa Pharmaceuticals (NASDAQ:CNTA) Coverage Initiated by Analysts at Oppenheimer
Oppenheimer assumed coverage on shares of Centessa Pharmaceuticals in a research note on Wednesday. They issued an "outperform" rating and a $62.00 target price on the stock...
MarketBeat·2d ago
News Placeholder
Stempoint Capital LP Increases Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA
Stempoint Capital LP boosted its position in Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Free Report) by 113.3% in the 2nd quarter, according to its most recent filing with the...
MarketBeat·2d ago
News Placeholder
Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Mario Alberto Accardi Sells 10,000 Shares of Stock
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) insider Mario Alberto Accardi sold 10,000 shares of the stock in a transaction that occurred on Monday, December 8th. The...
MarketBeat·3d ago
News Placeholder
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 10,000 Shares of Stock
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) insider Mario Alberto Accardi sold 10,000 shares of Centessa Pharmaceuticals stock in a transaction dated Monday, December...
MarketBeat·3d ago
News Placeholder
100,362 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Purchased by Bollard Group LLC
Bollard Group LLC bought a new stake in shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Free Report) in the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·5d ago
News Placeholder
Centessa Pharmaceuticals (NASDAQ:CNTA) Hits New 1-Year High - Still a Buy?
Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 12-Month High - Here's Why...
MarketBeat·6d ago
News Placeholder
B. Riley Research Analysts Raise Earnings Estimates for CNTA
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Free Report) - B. Riley raised their Q4 2025 earnings per share (EPS) estimates for Centessa Pharmaceuticals in a research note issued to...
MarketBeat·8d ago
News Placeholder
American Century Companies Inc. Raises Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA
American Century Companies Inc. boosted its stake in shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Free Report) by 3.5% in the 2nd quarter, according to the company in its most...
MarketBeat·8d ago
News Placeholder
B. Riley Raises Centessa Pharmaceuticals (NASDAQ:CNTA) Price Target to $42.00
B. Riley increased their price target on shares of Centessa Pharmaceuticals from $33.00 to $42.00 and gave the stock a "buy" rating in a report on Monday...
MarketBeat·10d ago

Latest CNTA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.